In many chronic inflammatory diseases, mast cells are central drivers of pathology. The paucity of mast cell-selective drugs leaves a huge unmet medical need in this area. Targeting of mast cells via indiscriminate blocking of c-KIT signalling, while potentially efficacious, can lead to severe, dose... Read more
This company has no teams yet
This company has no offices yet